A.   Increased serum albumin levels

B.   Increased urine specific gravity

C.   Decreased adrenocorticotropic hormone levels

D.   Relief of pain

A.   Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

B.   Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

C.   Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

D.   Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

A.   Choriomammotropin

B.   Somatostatin

C.   Somatropin

D.   Somatolactin

A.   Oxytocin

B.   Vasopressin

C.   Octreotide

D.   Cosyntropin

A.   Polyuria

B.   Hypopituitary dwarfism

C.   Acromegaly

D.   Polydipsia

A.   Vasopressin

B.   Luteinizing hormone

C.   Desmopressin

D.   Somatropin

A.   Creatinine clearance test

B.   Complete blood count result

C.   Uric acid level

D.   Blood glucose level

A.   Cyclosporine

B.   Demeclocycline

C.   Carbamazepine

D.   Ciprofloxacin

A.   Octreotide

B.   Thyroid hormone

C.   Cosyntropin

D.   Oxytocin

A.   Dehydration

B.   Headache

C.   Polydipsia

D.   Polyuria

A.   Somatropin

B.   Desmopressin

C.   Cosyntropin

D.   Octreotide

A.   Octreotide

B.   Vasopressin

C.   Desmopressin

D.   Somatropin

A.   Causes prolongation of QT interval

B.   Reduces the effects of desmopressin

C.   Produces an additive effect

D.   Enhances the effects of desmopressin

A.   Edema

B.   Inflammation

C.   Scar formation

D.   Hypotension

A.   Malaise, Dyspnea,

B.   Constipation, Malaise, Hypercalciuria

C.   Arthralgia, Hypercalciuria, Constipation

D.   Dyspnea, Constipation, Hypercalciuria

A.   Renal function studies, Liver enzyme levels, Blood pressure

B.   Weight, Blood pressure, Blood glucose levels

C.   Liver enzyme levels, Blood glucose levels, Renal function studies

D.   Liver enzyme levels, Renal function studies, Weight

A.   Norepinephrine

B.   Acetaminophen

C.   Thioridazine

D.   Carbamazepine

A.   Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

B.   Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

C.   Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

D.   Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

A.   Reduces fat levels

B.   Decreases fluid retention

C.   Reduces weight loss

D.   Decreases growth

A.   Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

B.   Seizure, Asthma, Cardiovascular disease

C.   Diabetes insipidus, Seizure, Type I von Willebrand

D.   Asthma, Diabetes insipidus, Type I von Willebrand

A.   Glucocorticoids

B.   Cyclosporine

C.   Ciprofloxacin

D.   Fludrocortisone

A.   Hyponatremia

B.   Orthostatic hypotension

C.   Hypokalemia

D.   Hyperglycemia

A.   Heartburn

B.   Hypoglycemia

C.   Seizures

D.   Edema

A.   Vasopressin and demeclocycline

B.   Somatropin and glucocorticoids

C.   Desmopressin and carbamazepine

D.   Vasopressin and carbamazepine

A.   A 7-year-old diagnosed with growth hormone deficiency

B.   A 10-year-old of short stature who has severe asthma

C.   A 17-year-old who is 5 feet tall

D.   An 8-year-old with a pituitary tumor

A.   Human immunodeficiency virus (HIV) infection

B.   Cachexia and closed growth plates

C.   Bilateral metastatic breast cancer

D.   Acute bronchitis with laryngitis

A.   Watery diarrhea

B.   Oozing blood

C.   Abundant, diluted urine

D.   Loss of consciousness

A.   "Dilute the drug preparation before administration."

B.   "Apply the drug preparation topically to the nasal membranes."

C.   "Inhale the drug preparation by spraying into the nostrils."

D.   "Shake the drug preparation thoroughly before use."

A.   Hypertension

B.   Hypercalciuria

C.   Hypothyroidism

D.   Hyperglycemia

A.   Replacing the cap on the pump after the procedure

B.   Pressing down on the pump two times to prime it

C.   Priming the nasal pump once a week

D.   Pressing the pump once to spray a 10-mcg dose

A.   Height, Weight, Motor skills

B.   Skin turgor, Height, Visual acuity

C.   Weight, Skin turgor, Visual acuity

D.   Motor skills, Visual acuity, Skin turgor

A.   "Is there any change in the color of your sputum?" "Do you have excessive bleeding due to minor injuries?"

B.   "Is there any change in the color of your urine?" "Is there any change in the color of your sputum?"

C.   "Do you have excessive bleeding due to minor injuries?" "Is there any change in the color of your urine?"

D.   "Do you feel very thirsty lately?" "How many times do you urinate in a day?"

A.   Storing the pump at room temperature

B.   Inhaling the medication into the airway

C.   Administering half the dose in each nostril

D.   Priming the pump each week

A.   The patient needs to adjust fluid intake.

B.   The patient is stable and needs reassurance.

C.   A higher dose of medication is required for treatment.

D.   The medication is not effective for this condition.

A.   Diarrhea, Flushing

B.   Joint pain, Fatigue

C.   Headache, Joint pain

D.   Fatigue, Headache

A.   Patient C: VIP; life-threatening hypotension; diarrhea and flushing

B.   Patient D: VIP; severe diarrhea and flushing; renal impairment

C.   Patient B: carcinoid tumor; taking ciprofloxacin

D.   Patient A: esophageal varices; type 1 diabetes

A.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Replace the cap on the bottle. 5. Give half a spray in each nostril. 6. Monitor the level of drug left in the pump.

B.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Give half a spray in each nostril. 5. Replace the cap on the bottle. 6. Monitor the level of drug left in the pump.

C.   1. Clear the nasal passages. 2. Give half a spray in each nostril. 3. Place the spray nozzle in the nostril. 4. Prime the pump by pressing down four times. 5. Replace the cap on the bottle. 6. Monitor the level of drug left in the pump.

D.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Give half a spray in each nostril. 5. Monitor the level of drug left in the pump. 6. Replace the cap on the bottle.

A.   Small-bowel fistula and having an acute asthma attack

B.   Acromegaly and a serum creatinine level of 5.0 mg/dL

C.   Esophageal varices and a history of type 2 diabetes

D.   Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

A.   Assess for signs of dehydration.

B.   Measure the patient’s urine output regularly.

C.   Make a note of the fluid intake.

D.   Watch the IV site closely for infiltration.

A.   Weight gain, Edema of the extremities

B.   Edema of the extremities, Elevated blood pressure

C.   Elevated blood pressure, Weight gain

D.   Increased urination, Thirst

A.   Assess the patient for headaches

B.   Notice increase in body temperature

C.   Monitor for signs of infiltration

D.   Inquire about abdominal discomfort

A.   Calculate the dosage with the pharmacist or another nurse

B.   Review current laboratory values for blood glucose

C.   Obtain baseline weight and height measurements

D.   Review the frequency with the health care provider

A.   Reports episodic muscle pain during the past year.

B.   Growth percentile has increased from the previous annual physical.

C.   Radiology report identifies no fracture with closed growth plates.

D.   Previous somatropin injection site tender to touch.

A.   Renal panel

B.   Blood glucose

C.   Electrocardiogram (ECG)

D.   Liver enzymes

A.   Octreotide subcutaneous

B.   Desmopressin intravenously

C.   Somatropin intramuscular

D.   Vasopressin nasal spray

A.   Nausea, Blood glucose elevation, Headache, Low urine output

B.   Nausea, Blood glucose elevation, Headache, Low blood pressure

C.   Low blood pressure, Blood glucose elevation, Headache, Low urine output

D.   Headache, Low urine output, Low blood pressure, Nausea

A.   Bleeding gums

B.   Abdominal cramps

C.   Limping

D.   Excessive thirst

A.   Obtaining liver and renal function tests

B.   Administering the vasopressin intravenously

C.   Co-administering carbamazepine

D.   Monitoring the patient in an intensive care unit

A.   Evaluate the patient for limping.

B.   Monitor fluid status.

C.   Monitor blood glucose levels closely.

D.   Encourage vigorous exercise.

A.   "Shake the medication before administration."

B.   "Do not administer the drug to the patient."

C.   "Heat the medicine before administration."

D.   "Keep the bottle in warm water before administration."

A.   Drowsiness

B.   Abdominal stress

C.   Vertigo

D.   Bleeding gums

A.   Desmopressin

B.   Vasopressin

C.   Cosyntropin

D.   Somatropin

A.   "If it is almost time for your next dose, take a double dose of the drug at that time."

B.   "You can take the dose immediately when you remember it."

C.   "Skip the missed dose and resume your usual dosage schedule."

D.   "You should consult your primary health care provider immediately."

A.   Somatropin

B.   Vasopressin

C.   Desmopressin

D.   Octreotide

A.   Somatropin

B.   Corticotropin

C.   Octreotide

D.   Desmopressin